Loading...
7731 logo

Nikon Community

TSE:7731 Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

Community Investing Ideas

7731 logo
Nikon

Acquisition Of RED And Growth In Cell Therapy Propel Revenue And Margins In Imaging And Healthcare

Key Takeaways Nikon's acquisition of RED enhances its video strategy, potentially boosting revenue in the Imaging Products Business. Nikon's pivot in the CDMO business, focusing on cell therapy, may solidify new revenue streams in the Healthcare sector.

View narrative
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
JP¥1.47k
23.8% overvalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
2.01% p.a.
Profit Margin
5.45%
Future PE
12.51x
Share price in 2028
JP¥1.82k